Cryptotanshinone Reverses Reproductive and Metabolic Disturbances in PCOS Model Rats via Regulating the Expression of CYP17 and AR

Table 5

Serum biochemical assessments by radioimmunoassay.

Radioimmunoassay index

T

A2

E2

LH

FSH

LH/FSH

SHBG

TC

TG

LDH-C

HDL-C

FPG

FINS

Group

Number

(nmol/L )

(nmol/L)

(pmol/L)

(IU/L)

(IU/L)

(IU/L)

(nmol/L)

(nmol/L)

(nmol/L)

(μmol/L)

(μmol/L)

(mIU/L)

(mIU/L)

Control group

10

0.76 ± 0.07

9.24 ± 2.34

88.76 ± 5.23

28.21 ± 3.82

12.42 ± 1.92

2.27 ± 0.13

40.52 ± 3.76

7.22 ± 1.37

1.00 ± 0.22

32.04 ± 7.56

81.68 ± 15.17

5.36 ± 0.09

5.57 ± 1.01

Model group

12

1.03 ± 0.14*

16.02 ± 6.31*

126.73 ± 17.08*

32.82 ± 1.22*

10.36 ± 2.25

3.17 ± 0.31*

28.52 ± 5.37*

8.63 ± 2.50*

1.89 ± 0.34

55.95 ± 9.85*

140.50 ± 19.91*

6.19 ± 0.17

13.79 ± 3.74*

Drug group

12

0.90 ± 0.11^△

12.31 ± 2.38^△

121.46 ± 9.56

29.04 ± 5.11^△

10.57 ± 2.41

2.75 ± 0.18^△

35.64 ± 4.82^△

7.68 ± 1.00

2.05 ± 0.44

49.89 ± 7.18^△

162.32 ± 30.51

6.25 ± 0.21

9.95 ± 1.68^△

Model group versus Control group: ^∗𝑃<0.05; Drug group versus Model group: ^△𝑃<0.05.